Context

A global pharmaceutical leader required a secure separation of its business during a high-stakes corporate demerger. The organization needed to ensure multinational compliance while simultaneously protecting operations, preserving customer trust, and creating value for shareholders in both the legacy and new entities.

Our Approach

ResilientTech Advisors architected the cybersecurity strategy for the separation. We enabled Board-level decision-making through tailored KRIs/KPIs, directed a global program with teams across the U.S., U.K., and Europe, and enhanced resilience through information-sharing partnerships with national security organizations. We also launched a third-party cyber risk rating system and negotiated favorable cyber liability coverage aligned with the company’s global exposure. Every step was framed around both protecting continuity and positioning the new organization to compete effectively from day one.

Impact

Related Services

“ResilientTech Advisors were instrumental in enabling a secure, compliant separation of our business. They brought structure, global coordination, and executive-level insight that allowed us to move at speed without sacrificing precision. Their leadership ensured we not only completed the demerger successfully but also created lasting value for our stakeholders.”

-Global CISO

This engagement reflects ResilientTech Advisors’ ability to lead complex global transformation efforts where security, speed, and regulatory precision are mission-critical to business continuity and market success.